nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—Pleural effusion—Sorafenib—liver cancer	0.0133	0.0436	CcSEcCtD
Procainamide—Pericarditis—Epirubicin—liver cancer	0.00873	0.0286	CcSEcCtD
Procainamide—Hepatic failure—Sorafenib—liver cancer	0.00825	0.027	CcSEcCtD
Procainamide—Pericarditis—Doxorubicin—liver cancer	0.00808	0.0264	CcSEcCtD
Procainamide—Cardiac failure—Sorafenib—liver cancer	0.0076	0.0249	CcSEcCtD
Procainamide—Abdominal pain upper—Sorafenib—liver cancer	0.00677	0.0222	CcSEcCtD
Procainamide—Abdominal discomfort—Sorafenib—liver cancer	0.00614	0.0201	CcSEcCtD
Procainamide—Neutropenia—Sorafenib—liver cancer	0.00599	0.0196	CcSEcCtD
Procainamide—Renal failure—Sorafenib—liver cancer	0.00562	0.0184	CcSEcCtD
Procainamide—Hepatomegaly—Epirubicin—liver cancer	0.00533	0.0174	CcSEcCtD
Procainamide—Hepatomegaly—Doxorubicin—liver cancer	0.00493	0.0161	CcSEcCtD
Procainamide—Pleural effusion—Epirubicin—liver cancer	0.00493	0.0161	CcSEcCtD
Procainamide—Cardiac disorder—Sorafenib—liver cancer	0.00476	0.0156	CcSEcCtD
Procainamide—Flushing—Sorafenib—liver cancer	0.00476	0.0156	CcSEcCtD
Procainamide—Pleural effusion—Doxorubicin—liver cancer	0.00456	0.0149	CcSEcCtD
Procainamide—Dysgeusia—Sorafenib—liver cancer	0.00437	0.0143	CcSEcCtD
Procainamide—Oliguria—Epirubicin—liver cancer	0.0041	0.0134	CcSEcCtD
Procainamide—Angioedema—Sorafenib—liver cancer	0.00408	0.0133	CcSEcCtD
Procainamide—Myalgia—Sorafenib—liver cancer	0.0038	0.0124	CcSEcCtD
Procainamide—Arthralgia—Sorafenib—liver cancer	0.0038	0.0124	CcSEcCtD
Procainamide—Oliguria—Doxorubicin—liver cancer	0.00379	0.0124	CcSEcCtD
Procainamide—Ventricular tachycardia—Epirubicin—liver cancer	0.00378	0.0123	CcSEcCtD
Procainamide—Shock—Sorafenib—liver cancer	0.00359	0.0117	CcSEcCtD
Procainamide—Thrombocytopenia—Sorafenib—liver cancer	0.00357	0.0117	CcSEcCtD
Procainamide—Ventricular tachycardia—Doxorubicin—liver cancer	0.00349	0.0114	CcSEcCtD
Procainamide—Anorexia—Sorafenib—liver cancer	0.00347	0.0114	CcSEcCtD
Procainamide—Rash maculo-papular—Epirubicin—liver cancer	0.00343	0.0112	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00332	0.0109	CcSEcCtD
Procainamide—Rash maculo-papular—Doxorubicin—liver cancer	0.00317	0.0104	CcSEcCtD
Procainamide—Decreased appetite—Sorafenib—liver cancer	0.00317	0.0104	CcSEcCtD
Procainamide—Sunitinib—KDR—liver cancer	0.00316	0.776	CrCbGaD
Procainamide—Hepatic failure—Epirubicin—liver cancer	0.00305	0.00997	CcSEcCtD
Procainamide—Gastrointestinal pain—Sorafenib—liver cancer	0.00298	0.00975	CcSEcCtD
Procainamide—Urticaria—Sorafenib—liver cancer	0.00289	0.00947	CcSEcCtD
Procainamide—Abdominal pain—Sorafenib—liver cancer	0.00288	0.00942	CcSEcCtD
Procainamide—Body temperature increased—Sorafenib—liver cancer	0.00288	0.00942	CcSEcCtD
Procainamide—Renal impairment—Epirubicin—liver cancer	0.00288	0.00942	CcSEcCtD
Procainamide—Hepatic failure—Doxorubicin—liver cancer	0.00282	0.00923	CcSEcCtD
Procainamide—Cardiac failure—Epirubicin—liver cancer	0.00281	0.00919	CcSEcCtD
Procainamide—Lethargy—Epirubicin—liver cancer	0.0028	0.00915	CcSEcCtD
Procainamide—Hypersensitivity—Sorafenib—liver cancer	0.00268	0.00878	CcSEcCtD
Procainamide—Renal impairment—Doxorubicin—liver cancer	0.00266	0.00872	CcSEcCtD
Procainamide—Asthenia—Sorafenib—liver cancer	0.00261	0.00855	CcSEcCtD
Procainamide—Cardiac arrest—Epirubicin—liver cancer	0.00261	0.00852	CcSEcCtD
Procainamide—Cardiac failure—Doxorubicin—liver cancer	0.0026	0.0085	CcSEcCtD
Procainamide—Lethargy—Doxorubicin—liver cancer	0.00259	0.00846	CcSEcCtD
Procainamide—Pruritus—Sorafenib—liver cancer	0.00258	0.00843	CcSEcCtD
Procainamide—Abdominal pain upper—Epirubicin—liver cancer	0.0025	0.00819	CcSEcCtD
Procainamide—Diarrhoea—Sorafenib—liver cancer	0.00249	0.00816	CcSEcCtD
Procainamide—Cardiac arrest—Doxorubicin—liver cancer	0.00241	0.00789	CcSEcCtD
Procainamide—Dizziness—Sorafenib—liver cancer	0.00241	0.00788	CcSEcCtD
Procainamide—Eosinophilia—Epirubicin—liver cancer	0.00234	0.00767	CcSEcCtD
Procainamide—Vomiting—Sorafenib—liver cancer	0.00232	0.00758	CcSEcCtD
Procainamide—Abdominal pain upper—Doxorubicin—liver cancer	0.00232	0.00758	CcSEcCtD
Procainamide—Neutropenia—Epirubicin—liver cancer	0.00221	0.00724	CcSEcCtD
Procainamide—Eosinophilia—Doxorubicin—liver cancer	0.00217	0.0071	CcSEcCtD
Procainamide—Nausea—Sorafenib—liver cancer	0.00216	0.00708	CcSEcCtD
Procainamide—Renal failure—Epirubicin—liver cancer	0.00208	0.00679	CcSEcCtD
Procainamide—Neutropenia—Doxorubicin—liver cancer	0.00205	0.0067	CcSEcCtD
Procainamide—Agranulocytosis—Epirubicin—liver cancer	0.00197	0.00645	CcSEcCtD
Procainamide—Bradycardia—Epirubicin—liver cancer	0.00193	0.00631	CcSEcCtD
Procainamide—Renal failure—Doxorubicin—liver cancer	0.00192	0.00628	CcSEcCtD
Procainamide—Agranulocytosis—Doxorubicin—liver cancer	0.00182	0.00596	CcSEcCtD
Procainamide—Bradycardia—Doxorubicin—liver cancer	0.00179	0.00584	CcSEcCtD
Procainamide—Flushing—Epirubicin—liver cancer	0.00176	0.00576	CcSEcCtD
Procainamide—Cardiac disorder—Epirubicin—liver cancer	0.00176	0.00576	CcSEcCtD
Procainamide—Chills—Epirubicin—liver cancer	0.0017	0.00556	CcSEcCtD
Procainamide—Flushing—Doxorubicin—liver cancer	0.00163	0.00533	CcSEcCtD
Procainamide—Cardiac disorder—Doxorubicin—liver cancer	0.00163	0.00533	CcSEcCtD
Procainamide—Dysgeusia—Epirubicin—liver cancer	0.00162	0.00529	CcSEcCtD
Procainamide—Chills—Doxorubicin—liver cancer	0.00157	0.00515	CcSEcCtD
Procainamide—Ill-defined disorder—Epirubicin—liver cancer	0.00153	0.00501	CcSEcCtD
Procainamide—Dysgeusia—Doxorubicin—liver cancer	0.0015	0.00489	CcSEcCtD
Procainamide—Malaise—Epirubicin—liver cancer	0.00149	0.00487	CcSEcCtD
Procainamide—Convulsion—Epirubicin—liver cancer	0.00143	0.00468	CcSEcCtD
Procainamide—Ill-defined disorder—Doxorubicin—liver cancer	0.00142	0.00463	CcSEcCtD
Procainamide—Arthralgia—Epirubicin—liver cancer	0.0014	0.0046	CcSEcCtD
Procainamide—Myalgia—Epirubicin—liver cancer	0.0014	0.0046	CcSEcCtD
Procainamide—Discomfort—Epirubicin—liver cancer	0.00139	0.00454	CcSEcCtD
Procainamide—Malaise—Doxorubicin—liver cancer	0.00138	0.0045	CcSEcCtD
Procainamide—Confusional state—Epirubicin—liver cancer	0.00136	0.00444	CcSEcCtD
Procainamide—Shock—Epirubicin—liver cancer	0.00133	0.00433	CcSEcCtD
Procainamide—Convulsion—Doxorubicin—liver cancer	0.00132	0.00433	CcSEcCtD
Procainamide—Thrombocytopenia—Epirubicin—liver cancer	0.00132	0.00431	CcSEcCtD
Procainamide—Myalgia—Doxorubicin—liver cancer	0.0013	0.00425	CcSEcCtD
Procainamide—Arthralgia—Doxorubicin—liver cancer	0.0013	0.00425	CcSEcCtD
Procainamide—Discomfort—Doxorubicin—liver cancer	0.00128	0.0042	CcSEcCtD
Procainamide—Anorexia—Epirubicin—liver cancer	0.00128	0.0042	CcSEcCtD
Procainamide—Hypotension—Epirubicin—liver cancer	0.00126	0.00412	CcSEcCtD
Procainamide—Confusional state—Doxorubicin—liver cancer	0.00126	0.00411	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00123	0.00401	CcSEcCtD
Procainamide—Shock—Doxorubicin—liver cancer	0.00123	0.00401	CcSEcCtD
Procainamide—Thrombocytopenia—Doxorubicin—liver cancer	0.00122	0.00399	CcSEcCtD
Procainamide—Anorexia—Doxorubicin—liver cancer	0.00119	0.00389	CcSEcCtD
Procainamide—Decreased appetite—Epirubicin—liver cancer	0.00117	0.00383	CcSEcCtD
Procainamide—Hypotension—Doxorubicin—liver cancer	0.00116	0.00381	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00114	0.00371	CcSEcCtD
Procainamide—Feeling abnormal—Epirubicin—liver cancer	0.00111	0.00363	CcSEcCtD
Procainamide—Gastrointestinal pain—Epirubicin—liver cancer	0.0011	0.0036	CcSEcCtD
Procainamide—Decreased appetite—Doxorubicin—liver cancer	0.00108	0.00354	CcSEcCtD
Procainamide—Urticaria—Epirubicin—liver cancer	0.00107	0.0035	CcSEcCtD
Procainamide—Abdominal pain—Epirubicin—liver cancer	0.00106	0.00348	CcSEcCtD
Procainamide—Body temperature increased—Epirubicin—liver cancer	0.00106	0.00348	CcSEcCtD
Procainamide—Feeling abnormal—Doxorubicin—liver cancer	0.00103	0.00336	CcSEcCtD
Procainamide—Gastrointestinal pain—Doxorubicin—liver cancer	0.00102	0.00333	CcSEcCtD
Procainamide—Hypersensitivity—Epirubicin—liver cancer	0.000992	0.00325	CcSEcCtD
Procainamide—Urticaria—Doxorubicin—liver cancer	0.00099	0.00324	CcSEcCtD
Procainamide—Abdominal pain—Doxorubicin—liver cancer	0.000985	0.00322	CcSEcCtD
Procainamide—Body temperature increased—Doxorubicin—liver cancer	0.000985	0.00322	CcSEcCtD
Procainamide—Asthenia—Epirubicin—liver cancer	0.000966	0.00316	CcSEcCtD
Procainamide—Pruritus—Epirubicin—liver cancer	0.000953	0.00312	CcSEcCtD
Procainamide—Diarrhoea—Epirubicin—liver cancer	0.000921	0.00301	CcSEcCtD
Procainamide—Hypersensitivity—Doxorubicin—liver cancer	0.000918	0.003	CcSEcCtD
Procainamide—Probenecid—ALB—liver cancer	0.000916	0.225	CrCbGaD
Procainamide—Asthenia—Doxorubicin—liver cancer	0.000894	0.00292	CcSEcCtD
Procainamide—Dizziness—Epirubicin—liver cancer	0.000891	0.00291	CcSEcCtD
Procainamide—Pruritus—Doxorubicin—liver cancer	0.000882	0.00288	CcSEcCtD
Procainamide—Vomiting—Epirubicin—liver cancer	0.000856	0.0028	CcSEcCtD
Procainamide—Diarrhoea—Doxorubicin—liver cancer	0.000853	0.00279	CcSEcCtD
Procainamide—Dizziness—Doxorubicin—liver cancer	0.000824	0.0027	CcSEcCtD
Procainamide—Nausea—Epirubicin—liver cancer	0.0008	0.00262	CcSEcCtD
Procainamide—Vomiting—Doxorubicin—liver cancer	0.000792	0.00259	CcSEcCtD
Procainamide—Nausea—Doxorubicin—liver cancer	0.00074	0.00242	CcSEcCtD
Procainamide—SCN10A—Developmental Biology—HRAS—liver cancer	0.000211	0.000305	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—HRAS—liver cancer	0.000211	0.000305	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—AKT1—liver cancer	0.00021	0.000304	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—F2—liver cancer	0.00021	0.000304	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NAT2—liver cancer	0.00021	0.000304	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—liver cancer	0.000209	0.000303	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—liver cancer	0.000209	0.000303	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—HRAS—liver cancer	0.000208	0.000301	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000207	0.000301	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.000207	0.0003	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CRABP1—liver cancer	0.000206	0.000298	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000206	0.000298	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—liver cancer	0.000205	0.000297	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000204	0.000296	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—STAT3—liver cancer	0.000203	0.000294	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—F2—liver cancer	0.000203	0.000294	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000202	0.000292	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—liver cancer	0.000202	0.000292	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—liver cancer	0.000202	0.000292	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HPGDS—liver cancer	0.000201	0.000292	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PSMA4—liver cancer	0.000201	0.000292	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PSMD10—liver cancer	0.000201	0.000292	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALDOB—liver cancer	0.000201	0.000291	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—AKT1—liver cancer	0.000201	0.000291	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.0002	0.00029	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—liver cancer	0.000199	0.000288	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GOT2—liver cancer	0.000196	0.000284	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—AKT1—liver cancer	0.000193	0.00028	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—AKT1—liver cancer	0.000193	0.00028	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTP1—liver cancer	0.000193	0.000279	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CRABP1—liver cancer	0.000192	0.000278	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000192	0.000278	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—HMOX1—liver cancer	0.00019	0.000276	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—liver cancer	0.000188	0.000273	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—F2—liver cancer	0.000187	0.000271	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—AKT1—liver cancer	0.000186	0.00027	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—AKT1—liver cancer	0.000186	0.00027	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000185	0.000268	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP2E1—liver cancer	0.000184	0.000267	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—liver cancer	0.000184	0.000267	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000182	0.000264	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.00018	0.000261	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HPGDS—liver cancer	0.00018	0.000261	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PSMD10—liver cancer	0.00018	0.00026	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PSMA4—liver cancer	0.00018	0.00026	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000178	0.000258	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MYC—liver cancer	0.000178	0.000258	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP2—liver cancer	0.000178	0.000258	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—HRAS—liver cancer	0.000178	0.000258	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTM1—liver cancer	0.000177	0.000257	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—liver cancer	0.000176	0.000255	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GOT2—liver cancer	0.000175	0.000253	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—KRAS—liver cancer	0.000174	0.000253	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000172	0.00025	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYCS—liver cancer	0.000172	0.000249	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GOT1—liver cancer	0.000169	0.000245	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GGT1—liver cancer	0.000169	0.000245	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FST—liver cancer	0.000168	0.000244	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP1A1—liver cancer	0.000168	0.000243	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HPGDS—liver cancer	0.000168	0.000243	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PRKCE—liver cancer	0.000165	0.000239	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2E1—liver cancer	0.000164	0.000238	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TRIO—liver cancer	0.00016	0.000232	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PSMD10—liver cancer	0.00016	0.000232	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PSMA4—liver cancer	0.00016	0.000232	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000159	0.00023	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP2—liver cancer	0.000159	0.00023	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—HRAS—liver cancer	0.000159	0.00023	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—liver cancer	0.000157	0.000227	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GOT2—liver cancer	0.000156	0.000226	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR4—liver cancer	0.000154	0.000223	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARA—liver cancer	0.000154	0.000223	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYCS—liver cancer	0.000154	0.000223	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000153	0.000222	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTP1—liver cancer	0.000152	0.00022	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GGT1—liver cancer	0.000151	0.000218	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GOT1—liver cancer	0.000151	0.000218	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCE—liver cancer	0.00015	0.000217	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HMOX1—liver cancer	0.00015	0.000217	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PSMA4—liver cancer	0.000149	0.000217	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PSMD10—liver cancer	0.000149	0.000217	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HRAS—liver cancer	0.000148	0.000215	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2E1—liver cancer	0.000147	0.000212	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CSF2—liver cancer	0.000146	0.000212	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GOT2—liver cancer	0.000145	0.000211	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CPT1B—liver cancer	0.000144	0.000208	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GLUL—liver cancer	0.000144	0.000208	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000143	0.000206	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—liver cancer	0.000142	0.000206	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—HRAS—liver cancer	0.000142	0.000205	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTM1—liver cancer	0.000139	0.000202	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NR1H4—liver cancer	0.000139	0.000201	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000138	0.0002	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYCS—liver cancer	0.000137	0.000199	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2E1—liver cancer	0.000137	0.000198	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CTNNB1—liver cancer	0.000137	0.000198	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTA3—liver cancer	0.000136	0.000197	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTP1—liver cancer	0.000135	0.000196	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GGT1—liver cancer	0.000135	0.000195	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GOT1—liver cancer	0.000135	0.000195	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMOX1—liver cancer	0.000134	0.000193	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CSF2—liver cancer	0.000133	0.000192	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP1A1—liver cancer	0.000132	0.000192	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—HRAS—liver cancer	0.000132	0.000191	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CG—liver cancer	0.000132	0.000191	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—liver cancer	0.000131	0.00019	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000129	0.000187	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYCS—liver cancer	0.000128	0.000185	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—liver cancer	0.000127	0.000184	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GOT1—liver cancer	0.000125	0.000182	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GGT1—liver cancer	0.000125	0.000182	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTA4—liver cancer	0.000125	0.000181	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTM1—liver cancer	0.000124	0.00018	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—liver cancer	0.000124	0.000179	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—liver cancer	0.000123	0.000179	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CTNNB1—liver cancer	0.000122	0.000176	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADAM17—liver cancer	0.000122	0.000176	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTA2—liver cancer	0.000121	0.000176	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARA—liver cancer	0.000121	0.000175	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTP1—liver cancer	0.000121	0.000175	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—liver cancer	0.000119	0.000173	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP1A1—liver cancer	0.000118	0.000171	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTA1—liver cancer	0.000117	0.00017	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NAT2—liver cancer	0.000116	0.000168	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CD—liver cancer	0.000116	0.000168	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—F2—liver cancer	0.000115	0.000166	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSMA4—liver cancer	0.000114	0.000166	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSMD10—liver cancer	0.000114	0.000166	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—liver cancer	0.000114	0.000165	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTP1—liver cancer	0.000113	0.000163	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—liver cancer	0.000111	0.000161	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTM1—liver cancer	0.000111	0.000161	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDOB—liver cancer	0.000111	0.000161	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—liver cancer	0.00011	0.000159	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CG—liver cancer	0.00011	0.000159	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000109	0.000157	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARA—liver cancer	0.000108	0.000156	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CRABP1—liver cancer	0.000106	0.000154	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP1A1—liver cancer	0.000105	0.000153	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—F2—liver cancer	0.000104	0.000151	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTM1—liver cancer	0.000104	0.00015	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CG—liver cancer	0.000104	0.00015	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CB—liver cancer	0.000101	0.000146	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—liver cancer	0.0001	0.000145	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CG—liver cancer	9.96e-05	0.000144	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—liver cancer	9.82e-05	0.000142	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1A1—liver cancer	9.82e-05	0.000142	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.69e-05	0.00014	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	9.64e-05	0.00014	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARA—liver cancer	9.64e-05	0.00014	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HPGDS—liver cancer	9.26e-05	0.000134	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CG—liver cancer	9.24e-05	0.000134	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—liver cancer	9.15e-05	0.000133	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CD—liver cancer	9.11e-05	0.000132	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—liver cancer	8.99e-05	0.00013	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARA—liver cancer	8.98e-05	0.00013	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—liver cancer	8.92e-05	0.000129	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCE—liver cancer	8.86e-05	0.000128	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	8.76e-05	0.000127	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	8.4e-05	0.000122	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF2—liver cancer	8.39e-05	0.000122	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSMD10—liver cancer	8.25e-05	0.00012	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSMA4—liver cancer	8.25e-05	0.00012	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CG—liver cancer	8.25e-05	0.00012	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CD—liver cancer	8.12e-05	0.000118	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT2—liver cancer	8.03e-05	0.000116	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—liver cancer	8.02e-05	0.000116	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—liver cancer	7.96e-05	0.000115	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CB—liver cancer	7.94e-05	0.000115	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CSF2—liver cancer	7.83e-05	0.000114	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RAF1—liver cancer	7.82e-05	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—H2AFX—liver cancer	7.72e-05	0.000112	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—liver cancer	7.72e-05	0.000112	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CG—liver cancer	7.69e-05	0.000111	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	7.63e-05	0.000111	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2E1—liver cancer	7.55e-05	0.000109	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—liver cancer	7.42e-05	0.000108	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CD—liver cancer	7.25e-05	0.000105	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—liver cancer	7.16e-05	0.000104	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CB—liver cancer	7.08e-05	0.000103	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYCS—liver cancer	7.06e-05	0.000102	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—liver cancer	7.01e-05	0.000102	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TERT—liver cancer	6.98e-05	0.000101	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT1—liver cancer	6.93e-05	0.0001	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GGT1—liver cancer	6.93e-05	0.0001	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CD—liver cancer	6.76e-05	9.8e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—liver cancer	6.68e-05	9.67e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KDR—liver cancer	6.39e-05	9.25e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK14—liver cancer	6.34e-05	9.19e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CB—liver cancer	6.32e-05	9.16e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTP1—liver cancer	6.23e-05	9.02e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ESR1—liver cancer	6.22e-05	9.02e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—F2—liver cancer	6.15e-05	8.91e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CA—liver cancer	6.15e-05	8.9e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—liver cancer	6.14e-05	8.9e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CB—liver cancer	5.89e-05	8.54e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APC—liver cancer	5.88e-05	8.52e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CG—liver cancer	5.88e-05	8.52e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTM1—liver cancer	5.72e-05	8.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BRAF—liver cancer	5.53e-05	8.01e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1A1—liver cancer	5.42e-05	7.86e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CD—liver cancer	5.17e-05	7.49e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	5.12e-05	7.42e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—liver cancer	5.12e-05	7.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—KRAS—liver cancer	5.06e-05	7.34e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—liver cancer	5.06e-05	7.33e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—liver cancer	5.02e-05	7.27e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARA—liver cancer	4.96e-05	7.19e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CA—liver cancer	4.84e-05	7.01e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	4.65e-05	6.74e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RAF1—liver cancer	4.62e-05	6.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MTOR—liver cancer	4.51e-05	6.53e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CB—liver cancer	4.51e-05	6.53e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CA—liver cancer	4.32e-05	6.25e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HRAS—liver cancer	4.3e-05	6.24e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CG—liver cancer	4.25e-05	6.16e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1B—liver cancer	4.23e-05	6.13e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—liver cancer	4.19e-05	6.06e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP3—liver cancer	4.15e-05	6.01e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—liver cancer	4.14e-05	6e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—liver cancer	4.12e-05	5.97e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—liver cancer	4.1e-05	5.94e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—liver cancer	4.04e-05	5.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JUN—liver cancer	4.03e-05	5.84e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CTNNB1—liver cancer	4e-05	5.79e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—liver cancer	3.95e-05	5.73e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—liver cancer	3.92e-05	5.68e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1A—liver cancer	3.9e-05	5.66e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CA—liver cancer	3.85e-05	5.58e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK8—liver cancer	3.81e-05	5.52e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—liver cancer	3.8e-05	5.51e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CD—liver cancer	3.73e-05	5.41e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—liver cancer	3.69e-05	5.34e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CA—liver cancer	3.59e-05	5.21e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—liver cancer	3.53e-05	5.11e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—liver cancer	3.52e-05	5.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—liver cancer	3.48e-05	5.05e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CB—liver cancer	3.26e-05	4.72e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—liver cancer	3.24e-05	4.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—liver cancer	3.23e-05	4.68e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—liver cancer	3.15e-05	4.56e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KRAS—liver cancer	2.99e-05	4.33e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—liver cancer	2.94e-05	4.25e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CA—liver cancer	2.75e-05	3.98e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—liver cancer	2.66e-05	3.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRAS—liver cancer	2.54e-05	3.68e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—liver cancer	2.43e-05	3.53e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—liver cancer	2.25e-05	3.25e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CA—liver cancer	1.98e-05	2.88e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—liver cancer	1.62e-05	2.35e-05	CbGpPWpGaD
